IP Library Granted Patent US 11,353,467
Granted Patent B2
US 11,353,467 · App. 14/761,587 · Granted Jun 7, 2022

Use of lipid particles in medical diagnostics

Inventors: Katherine B. Louie (Walnut Creek, CA); Benjamin P. Bowen (Walnut Creek, CA); Trent R. Northen (Walnut Creek, CA)
Assignee: The Regents of the University of California
G01N33/92G01N33/574G01N2405/04G01N2405/08G01N2458/15G01N2560/00G01N2800/7028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,353,467
App. No.
14/761,587
Granted
Jun 7, 2022
Kind
B2
Abstract

Disclosed herein are methods for identifying one or more diseased cells in a subject. Some embodiments include providing a biological sample derived from a subject, analyzing the biological sample by mass spectrometry, and determining the abundance of one or more lipids in the biological sample, wherein an altered abundance of the one or more lipids in the biological sample, as compared to a reference level, indicates a presence of one or more diseased cells in the subject from which the biological sample is derived.

Claims (14)

1. A method for identifying one or more diseased cells in a subject, comprising:

(a) providing a cell culture derived from a biological sample of a subject;

(b) analyzing a crude extract of the cell culture by mass spectrometry on a nanostructure-initiator mass spectrometry (NIMS) chip having a perfluorinated coat;

(c) determining the abundance of one or more lipids in the cell culture, wherein an altered abundance of the one or more lipids in the cell culture, as compared to a reference level, identifies a subject as having one or more diseased cells, wherein the one or more diseased cells comprise cancer cells, wherein at least one of the one or more lipids comprises a lipid detected by mass spectrometry, wherein the at least one of the one or more lipids comprises PC(30:0), PE(36:2), PC(P-34:0), PE(P-34:1), PS(36:1), PE(34:1), PE(36:1), Glucosylceramide (d18:1/16:0), PC(34:0), PE(P-36: 4), PE(38: 1), Glucosylceramide (d18: 1/22:0), Glucosylceramide (d18:1/24:1), PE(34:2), or a combination thereof; and

(d) treating the subject identified as having one or more diseased cells with one or more anti-cancer agents.

2. The method of claim 1 , wherein the reference level is established using a reference sample from a healthy subject.

3. The method of claim 1 , wherein the cell culture comprises one or more lipid-containing microparticles.

4. The method of claim 3 , wherein the one or more lipid-containing microparticles are exosomes, cell membrane fragments, cellular and intracellular organelle fragments, lipid bilayers, or a combination thereof.

5. The method of claim 1 , wherein determining the abundance of one or more lipids in the cell culture comprises determining the lipid composition of the cell culture.

6. The method of claim 1 , wherein at least one of the one or more lipids is a monounsaturated lipid or a saturated lipid.

7. The method of claim 1 , wherein at least one of the one or more lipids comprises a lipid detected by mass spectrometry at about m/z 648.6304, at about m/z 538.5207, at about m/z 722.5574, at about m/z 700.5739, at about m/z 756.6337, at about m/z 778.6181, at about m/z 810.6781, at about m/z 832.6667, at about m/z 784.6613, at about m/z 806.6432, at about m/z 812.6909, at about m/z 834.679337, at about m/z 496.3414, at about m/z 524.373, at about m/z 522.3571, at about m/z 546.3553, at about m/z 454.294, at about m/z 482.3278, at about m/z 480.3097, at about m/z 678.508, at about m/z 676.4939, at about m/z 674.4662, at about m/z 706.5404, at about m/z 734.5717, at about m/z 732.5562, at about m/z 730.5439, at about m/z 728.5267, at about m/z 762.6029, at about m/z 760.5881, at about m/z 758.5715, at about m/z 756.5589, at about m/z 754.5394, at about m/z 788.6188, at about m/z 786.6026, at about m/z 784.5883, at about m/z 782.5723, at about m/z 810.605, at about m/z 808.5852, at about m/z 806.5714, at about m/z 834.6105, at about m/z 832.5859, at about m/z 692.5608, at about m/z 718.5761, at about m/z 746.6074, at about m/z 690.5083, at about m/z 720.5563, at about m/z 716.5241, at about m/z 746.5716, at about m/z 744.5557, at about m/z 742.5397, at about m/z 774.6024, at about m/z 772.5866, at about m/z 770.5705, at about m/z 768.554, at about m/z 766.5399, at about m/z 674.5134, at about m/z 704.555, at about m/z 702.5451, at about m/z 700.5293, at about m/z 730.5768, at about m/z 728.5592, at about m/z 726.5444, at about m/z 724.5292, at about m/z 758.6063, at about m/z 754.5757, at about m/z 752.5608, at about m/z 752.5595, at about m/z 750.5451, at about m/z 748.531, at about m/z 784.628, at about m/z 778.5781, at about m/z 776.5621, at about m/z 774.5456, at about m/z 689.5612, at about m/z 711.5457, at about m/z 749.5355, at about m/z 766.5602, at about m/z 747.5208, at about m/z 764.5472, at about m/z 777.566, at about m/z 794.5945, at about m/z 775.5505, at about m/z 792.5765, at about m/z 762.5297, at about m/z 790.5614, at about m/z 788.5477, at about m/z 838.5617, at about m/z 836.5452, at about m/z 675.5451, at about m/z 705.5839, at about m/z 703.5774, at about m/z 731.6081, at about m/z 815.7008, at about m/z 732.6077, at about m/z 787.6636, at about m/z 813.6856, at about m/z 835.6672, at about m/z 835.6659, at about m/z 701.5613, or a combination thereof.

8. The method of claim 1 , wherein the cell culture comprises exosomes.

9. The method of claim 1 , wherein the at least one of the one or more lipids comprises PC(30:0).

10. The method of claim 1 , wherein the at least one of the one or more lipids comprises PC(30:0), PE(36:2), PC(P-34:0), PE(P-34:1), PS(36:1), PE(34:1), PE(36: 1), Glucosylceramide (d18: 1/16: 0), PC(34:0), PE(P-36: 4), PE(38: 1), Glucosylceramide (d18:1/22:0), Glucosylceramide (d18:1/24:1), and PE(34:2).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: LOUIE, KATHERINE B; BOWEN, BENJAMIN P; NORTHEN, TRENT R
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038037/0017 →
CONFIRMATORY LICENSE Recorded Oct 7, 2015
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 036815/0551 →
Continuity (3)
Provisional Application 61756401 · Jan 24, 2013
Related Publication 20160003855A1 · Jan 7, 2016
Related Publication 20170030935A9 · Feb 2, 2017
Cited By (1)
US 12,196,748